BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 2243140)

  • 1. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
    Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
    J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.
    Weiss HJ; Hawiger J; Ruggeri ZM; Turitto VT; Thiagarajan P; Hoffmann T
    J Clin Invest; 1989 Jan; 83(1):288-97. PubMed ID: 2910912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
    Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
    J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen.
    Fressinaud E; Girma JP; Sadler JE; Baumgartner HR; Meyer D
    Thromb Haemost; 1990 Dec; 64(4):589-93. PubMed ID: 2084945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen gamma-chain carboxy terminal peptides.
    Hantgan RR; Endenburg SC; Cavero I; Marguerie G; Uzan A; Sixma JJ; de Groot PG
    Thromb Haemost; 1992 Dec; 68(6):694-700. PubMed ID: 1287884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction.
    Nurden AT; Nurden P
    Baillieres Clin Haematol; 1993 Sep; 6(3):653-90. PubMed ID: 8025347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein IIb-IIIa and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions.
    Nievelstein PF; Sixma JJ
    Blood; 1988 Jul; 72(1):82-8. PubMed ID: 2968824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: effects on platelet spreading and ultrastructure on human arterial subendothelium.
    Lawrence JB; Gralnick HR
    J Lab Clin Med; 1987 Apr; 109(4):495-503. PubMed ID: 2434592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
    Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
    J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746.
    Berliner S; Niiya K; Roberts JR; Houghten RA; Ruggeri ZM
    J Biol Chem; 1988 Jun; 263(16):7500-5. PubMed ID: 2453507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet-von Willebrand factor binding to platelets by adhesion site peptides.
    Parker RI; Gralnick HR
    Blood; 1989 Sep; 74(4):1226-30. PubMed ID: 2548639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.
    Sakariassen KS; Nievelstein PF; Coller BS; Sixma JJ
    Br J Haematol; 1986 Aug; 63(4):681-91. PubMed ID: 2942171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium.
    Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R
    Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
    Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
    J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S; Gralnick H
    Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM
    Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.